Pediatric Neurology
Volume 29, Issue 4 , Pages 321-325 , October 2003

Reversible infantile hypoglycorrhachia: possible transient disturbance in glucose transport?

  • Jörg Klepper, MD

      Affiliations

    • Department of Pediatric Neurology, University of Essen, Essen, Germany
    • Corresponding Author InformationCommunications should be addressed to:Dr. Klepper; University of Essen, Department of Pediatric Neurology; Hufelandstraβe 55; D-45122 Essen; Germany.
    • ,
  • Darryl C De Vivo, MD

      Affiliations

    • Department of Pediatric Neurology, Columbia University College of Physicians and Surgeons, New York, New York, USA
    • ,
  • David W Webb, MD

      Affiliations

    • Department of Neurology, Our Lady’s Hospital for Sick Children, Crumlin, Dublin, Ireland
    • ,
  • Lars Klinge, MD

      Affiliations

    • Department of Pediatric Neurology, University of Essen, Essen, Germany
    • ,
  • Thomas Voit, MD

      Affiliations

    • Department of Pediatric Neurology, University of Essen, Essen, Germany

Received 9 January 2003 ,Accepted 22 April 2003.

References 

  1. Vannucci SJ, Maher F, Simpson IA. Glucose transporter proteins in brain (Delivery of glucose to neurons and glia). Glia. 1997;21:2–21
  2. De Vivo DC, Trifiletti RR, Jacobson RI, Ronen GM, Behmand RA, Harik SI. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med. 1991;325:703–709
  3. De Vivo D, Garcia-Alvarez M, Ronen G, Trifiletti R. Glucose transport protein deficiency (An emerging syndrome with therapeutic implications). International Pediatrics. 1995;10:51–56
  4. Brockmann K, Wang D, Korenke CG, et al.  Autosomal dominant glut-1 deficiency syndrome and familial epilepsy. Ann Neurol. 2001;50:476–485
  5. Klepper J, Willemsen M, Verrips A, et al.  Autosomal dominant transmission of GLUT1 deficiency. Hum Mol Genet. 2001;10:63–68
  6. Seidner G, Alvarez MG, Yeh JI, et al.  GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nat Genet. 1998;18:188–191
  7. Wang D, Kranz-Eble P, De Vivo DC. Mutational analysis of GLUT1 (SLC2A1) in Glut-1 deficiency syndrome. Hum Mutat. 2000;16:224–231
  8. Klepper J, Voit T. Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome (Impaired glucose transport into brain—a review). Eur J Pediatr. 2002;161:295–304
  9. Nordli DR, De Vivo DC. The ketogenic diet revisited (Back to the future). Epilepsia. 1997;38:743–749
  10. Klepper J, Garcia-Alvarez M, O’Driscoll KR, et al.  Erythrocyte 3-O-methyl-D-glucose uptake assay for diagnosis of glucose-transporter-protein syndrome. J Clin Lab Anal. 1999;13:116–121
  11. Klepper J, Wang D, Fischbarg J, et al.  Defective glucose transport across brain tissue barriers (A newly recognized neurological syndrome). Neurochem Res. 1999;24:587–594
  12. Klepper J, Leiendecker B, Bredahl R, et al.  Introduction of a ketogenic diet in young infants. J Inherit Metab Dis. 2002;25:449–460
  13. Fishman RA. Decreased CSF glucose levels. In:  Fishman RA editors. Cerebrospinal fluid in diseases of the nervous system. Philadelphia: WB Saunders; 1992;p. 219–221
  14. Haspel HC, Stephenson KN, Davies-Hill T, et al.  Effects of barbiturates on facilitative glucose transporters are pharmacologically specific and isoform selective. J Membr Biol. 1999;169:45–53
  15. Klepper J, Fischbarg J, Vera JC, Wang D, De Vivo DC. GLUT1-deficiency (Barbiturates potentiate haploinsufficiency in vitro). Pediatr Res. 1999;46:677–683
  16. Maher F, Vannucci S, Takeda J, Simpson IA. Expression of mouse-GLUT3 and human-GLUT3 glucose transporter proteins in brain. Biochem Biophys Res Commun. 1992;182:703–711
  17. Maher F, Vannucci SJ, Simpson IA. Glucose transporter proteins in brain. Faseb J. 1994;8:1003–1011
  18. Cornford EM, Hyman S, Cornford ME, Landaw EM, Delgado-Escueta AV. Interictal seizure resections show two configurations of endothelial Glut1 glucose transporter in the human blood-brain barrier. J Cereb Blood Flow Metab. 1998;18:2642
  19. Cornford EM, Hyman S, Cornford ME, Caron MJ. Glut1 glucose transporter activity in human brain injury. J Neurotrauma. 1996;13:523–536
  20. Rosenstein JM, More NS. Immunocytochemical expression of the blood-brain barrier glucose transporter (GLUT-1) in neural transplants and brain wounds. J Comp Neurol. 1994;350:229–240
  21. Gamelli RL, Liu H, He LK, Hofmann CA. Alterations of glucose transporter mRNA and protein levels in brain following thermal injury and sepsis in mice. Shock. 1994;1:395–400
  22. Kovitz CA, Morgello S. Cerebral glucose transporter expression in HIV infection. Acta Neuropathol (Berl). 1997;94:140–145
  23. Brown GK. Glucose transporters (Structure, function and consequences of deficiency). J Inherit Metab Dis. 2000;23:237–246
  24. Vera JC, Reyes AM, Carcamo JG, et al.  Genistein is a natural inhibitor of hexose and dehydroascorbic acid transport through the glucose transporter, GLUT1. J Biol Chem. 1996;271:8719–8724
  25. Wellner M, Mueckler MM, Keller K. GTP analogs suppress uptake but not transport of D-glucose analogs in Glut1 glucose transporter-expressing Xenopus oocytes. FEBS Lett. 1993;327:95–98
  26. Pinkofsky HB, Dwyer DS, Bradley RJ. The inhibition of GLUT1 glucose transport and cytochalasin B binding activity by tricyclic antidepressants. Life Sci. 2000;66:271–278
  27. Ho YY, Yang H, Klepper J, Fischbarg J, Wang D, De Vivo DC. Glucose transporter type 1 deficiency syndrome (glut1ds) (Methylxanthines potentiate glut1 haploinsufficiency in vitro). Pediatr Res. 2001;50:254–260
  28. Hu IC, Singh SP, Snyder AK. Effects of ethanol on glucose transporter expression in cultured hippocampal neurons. Alcohol Clin Exp Res. 1995;19:1398–1402
  29. Krauss SW, Diamond I, Gordon AS. Selective inhibition by ethanol of the type 1 facilitative glucose transporter (GLUT1). Mol Pharmacol. 1994;45:1281–1286
  30. Van Coster RN, Fernhoff PM, De Vivo DC. Pyruvate carboxylase deficiency (A benign variant with normal development). Pediatr Res. 1991;30:1–4
  31. Di Mauro S, Nicholson JF, Hays AP, et al.  Benign infantile mitochondrial myopathy due to reversible cytochrome c oxidase deficiency. Ann Neurol. 1983;14:225–234

PII: S0887-8994(03)00268-6

doi: 10.1016/S0887-8994(03)00268-6

Pediatric Neurology
Volume 29, Issue 4 , Pages 321-325 , October 2003

Article Tools

* Image Usage & Resolution